GEHC GE HealthCare Technologies Inc

Price (delayed)

$80.66

Market cap

$36.47B

P/E Ratio

17.02

Dividend/share

$0.15

EPS

$4.74

Enterprise value

$43.59B

?
Relative Growth: Rel. Growth: 45
Relative Strength: Rel. Strength: 75
Relative Valuation: Rel. Valuation: 65
Relative Profitability: Rel. Profitability: 65

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make ...

Highlights
The company's equity rose by 16% YoY and by 6% QoQ
The quick ratio has grown by 7% from the previous quarter
GEHC's net income is up by 9% since the previous quarter but it is down by 2.8% year-on-year
The EPS has increased by 9% since the previous quarter but it has declined by 2.3% year-on-year
GEHC's price to earnings (P/E) is 6% higher than its last 4 quarters average of 15.9
The gross margin has contracted by 2.2% YoY

Key stats

What are the main financial stats of GEHC

GEHC stock price

How has the GE HealthCare Technologies stock price performed over time
Intraday
1.4%
1 week
13.43%
1 month
25.46%
1 year
8.31%
YTD
-1.66%
QTD
23.39%

Financial performance

How have GE HealthCare Technologies's revenue and profit performed over time
Revenue
$21.64B
Gross profit
$8.64B
Operating income
$2.89B
Net income
$2.15B
Gross margin
39.9%
Net margin
10%
GEHC's net income is up by 9% since the previous quarter but it is down by 2.8% year-on-year
The net margin has declined by 9% year-on-year but it has increased by 8% since the previous quarter
GE HealthCare Technologies's revenue has increased by 7% YoY
GE HealthCare Technologies's operating income has increased by 6% from the previous quarter and by 6% YoY

Price vs fundamentals

How does GEHC's price correlate with its fundamentals

Growth

What is GE HealthCare Technologies's growth rate over time

Valuation

What is GE HealthCare Technologies stock price valuation
P/E
17.02
P/B
3.14
P/S
1.68
EV/EBIT
13.83
EV/EBITDA
11.55
EV/Sales
2.01
The EPS has increased by 9% since the previous quarter but it has declined by 2.3% year-on-year
GEHC's price to earnings (P/E) is 6% higher than its last 4 quarters average of 15.9
The company's equity rose by 16% YoY and by 6% QoQ
The P/B is 3% higher than the last 4 quarters average of 3.0
GEHC's P/S is 11% above its last 4 quarters average of 1.5
GE HealthCare Technologies's revenue has increased by 7% YoY

Efficiency

How efficient is GE HealthCare Technologies business performance
The ROE has contracted by 17% YoY but it has grown by 4.2% from the previous quarter
GE HealthCare Technologies's return on invested capital has decreased by 16% YoY
GEHC's ROA is down by 9% YoY but it is up by 7% QoQ
The return on sales has declined by 6% year-on-year but it has increased by 2.8% since the previous quarter

Dividends

What is GEHC's dividend history
DPS
$0.15
Dividend yield
0.18%
Payout ratio
3.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did GE HealthCare Technologies financials performed over time
The total assets is 45% greater than the total liabilities
GEHC's current ratio is up by 10% year-on-year and by 3.2% since the previous quarter
The quick ratio has grown by 7% from the previous quarter
The debt is 14% smaller than the equity
GEHC's debt to equity is down by 17% YoY and by 7% from the previous quarter
The company's equity rose by 16% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.